Abstract:Organoids, which are miniature in vitro versions of organs, possess significant potential for studying human diseases and elucidating their underlying mechanisms. Live imaging techniques play a crucial role in organoid research and contribute to elucidating the complex structure and dynamic biological phenomena of organoids. However, live, unlabeled high-resolution imaging of native organoids is challenging, primarily owing to the complexities of sample handling and optical scattering inherent in three-dimensional (3D) structures. Additionally, conventional imaging methods fail to capture the real-time dynamic processes of growing organoids. In this study, we introduce low-coherence holotomography as an advanced, label-free, quantitative imaging modality designed to overcome several technical obstacles for long-term live imaging of 3D organoids. We demonstrate the efficacy of low-coherence holotomography by capturing high-resolution morphological details and dynamic activities within mouse small intestinal organoids at subcellular resolution. Moreover, our approach facilitates the distinction between viable and nonviable organoids, significantly enhancing its utility in organoid-based research. This advancement underscores the critical role of live imaging in organoid studies, offering a more comprehensive understanding of these complex systems. Organoids, miniature 3D structures that imitate real organs, are grown in labs to study human biology and diseases. However, their complex structures and behaviors are hard to understand due to imaging technology limitations. In this study, researchers used a method called low-coherence holotomography to study mouse small intestinal organoids. This method let them observe organoids' growth and drug responses in real-time, without altering their natural state. They conducted an experiment involving over 120 hours of continuous imaging, providing new insights into organoid development, cell dynamics, and drug responses. The study shows that low-coherence HT can reveal detailed 3D structures and changes within organoids, such as cell division and death, with high resolution. This research could revolutionize drug development and testing and provide new insights into human biology and diseases. This summary was initially drafted using artificial intelligence, then revised and fact-checked by the author.

Mass Spectrometry Imaging of Organoids to Improve Pre‐Clinical Research

Mass Spectrometry Imaging and Histology for the Analysis of Budding Intestinal Organoids

Molecular Imaging of Human Brain Organoids Using Mass Spectrometry

MS imaging of multicellular tumor spheroids and organoids as an emerging tool for personalized medicine and drug discovery

Mass spectrometry imaging as an emerging tool for studying metabolism in human brain organoids

Mass Spectrometry Imaging and Integration with Other Imaging Modalities for Greater Molecular Understanding of Biological Tissues

Cellular resolution in clinical MALDI mass spectrometry imaging: the latest advancements and current challenges

A vision for better health: mass spectrometry imaging for clinical diagnostics.

From Pixel To Voxel: A Deeper View Of Biological Tissue By 3d Mass Spectral Imaging

Revealing the clinical potential of high-resolution organoids

From molecules to visuals: Empowering drug discovery and development with mass spectrometry imaging

Quantitative Mass Spectrometry Imaging: Therapeutics & Biomolecules

Organoids for Cancer Research: Advances and Challenges

Non-invasive label-free imaging analysis pipeline for in situ characterization of 3D brain organoids

The Exploration of Microbial Natural Products and Metabolic Interaction Guided by Mass Spectrometry Imaging

Toward Mass Spectrometry Imaging in the Metabolomics Scale: Increasing Metabolic Coverage Through Multiple On-Tissue Chemical Modifications

Non-Invasive Label-free Analysis Pipeline for In Situ Characterization of Differentiation in 3D Brain Organoid Models

Long-term three-dimensional high-resolution imaging of live unlabeled small intestinal organoids via low-coherence holotomography

Mass spectrometry imaging and its application in pharmaceutical research and development: A concise review

Mass Spectrometry-Based Omics and Imaging Technique: A Novel Tool for Molecular Toxicology and Health Impacts